Codex DNA, Inc. , a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
Telesis Bio stock last closed at $2.06, up 1.48% from the previous day, and has decreased 77.01% in one year. It has underperformed other stocks in the Medical Devices industry by 0.6 percentage points. Telesis Bio stock is currently +90.74% from its 52-week low of $1.08, and -81.31% from its 52-week high of $11.02.
There are currently 29.52M shares of TBIO outstanding. The market cap of TBIO is $60.81M. In the last 24 hours, 21,401 TBIO shares were traded.
How to Buy Telesis Bio Stock
Not sure how to invest in Telesis Bio stock? Here's how.
Figure out where to buy Telesis Bio stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Telesis Bio stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Pick your payment method and add your details.
Analyze Telesis Bio stock: The Telesis Bio ticker symbol is TBIO. Is Telesis Bio stock a good investment? Should you buy shares of TBIO? How do TBIO's underlying business fundamentals look? Do top analysts think Telesis Bio is a good buy? Why has TBIO's stock price moved recently? (Hint: Our stock analysis website can help you understand if TBIO is a good stock to buy).
Execute your TBIO trade: Decide if you will purchase TBIO shares at the current market price or use a limit order to buy TBIO stock at a given price.
Get notifications regarding your TBIO position: Create a watchlist to keep track of your investment in Telesis Bio shares.
Step 1: Figure out where to buy Telesis Bio stock
You will need a brokerage account in order to access the NASDAQ market and buy TBIO stock.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today.
Once you have decided on the best place to buy Telesis Bio stock, it's crucial to research their stock prior to buying, so you can understand the risk and upside.
Overview of key TBIO info
TBIO Price
$2.06
1w %
13.19%
1y %
-77.01%
5y %
N/A
P/E
-1.23x
P/B
1.14x
P/S
2.89x
PEG
N/A
Revenue
$21.04M
Earnings
-$52.83M
Fore. Rev. Growth
82.9%
Fore. Earn. Growth
N/A
Market Cap
$60.81M
Next Earnings
Mar 21, 2023
Next Dividend
N/A
TBIO Fundamentals
WallStreetZen was built to help everyday investors perform better fundamental analysis in less time.
There are more short-term assets than short-term liabilities on the TBIO balance sheet.
There are more short-term assets than long-term liabilities on the TBIO balance sheet.
Failed Financial Due Diligence Checks:
TBIO profit margin has gone up by 0.73 percentage points in the past year, but the company is still unprofitable.
TBIO has $49.93M in cash and short term investments. This is not sufficient to cover its annual cash burn of $50.58M.
TBIO has cash burn of 50576000. It does not have enough cash and short-term investments to cover this.
TBIO has a relatively high debt to equity ratio of 0.65.
Is TBIO stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Wall Street analysts who monitor TBIO, the consensus analyst rating on Telesis Bio is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest TBIO Analyst Forecasts
Paul Knight, a top 9% analyst from KeyBanc maintains TBIO with a strong buy rating and lowers their TBIO price target from $8.00 to $5.00, on Nov 9, 2022.
Last year, TBIO revenue was $21.04M. During the past one years, TBIO's revenue has grown by 112.52% per year. This was faster than the Medical Devices industry average of 16.11%.
No, Telesis Bio doesn't provide an income stream by paying out dividends.
What others are saying about TBIO
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your TBIO trade
You have two primary options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly the easiest way to buy.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a specific price limit, use a limit order.
Press the Open button and eToro will execute the order.
If you require additional help investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Telesis Bio share?
As of Feb 6, 2023, it costs $2.06 to buy one share of Telesis Bio stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.485 shares of TBIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.